collaborators

5 papers

cs.CL2026

DrugClaw and DrugAudit: A Primary-Source-Grounded Agent and Authority-Aware Benchmark for Drug-Information Question Answering

Qing Wang, Bo Li, Jialu Liang +3

Drug-information question answering is a high-stakes setting where hallucinated facts can mislead clinical decision-making and the provenance of each cited fact matters as much as…

cs.CL2026

UniD: A Knowledge Graph-Enhanced RAG Framework for Drug-Disease Discovery and Reasoning

Qing Wang, Tianshi Liu, Minghao Zhou +5

Systematic characterization of drug-disease relationships is essential for drug discovery and repurposing, yet is hindered by the heterogeneity and rapid growth of biomedical liter…

cs.AI2025

scDrugMap: Benchmarking Large Foundation Models for Drug Response Prediction

Qing Wang, Yining Pan, Minghao Zhou +4

Drug resistance presents a major challenge in cancer therapy. Single cell profiling offers insights into cellular heterogeneity, yet the application of large-scale foundation model…

cs.LG2025

PhenoProfiler: Advancing Phenotypic Learning for Image-based Drug Discovery

Bo Li, Bob Zhang, Chengyang Zhang +7

In the field of image-based drug discovery, capturing the phenotypic response of cells to various drug treatments and perturbations is a crucial step. However, existing methods req…

cs.CE2025

HECLIP: Histology-Enhanced Contrastive Learning for Imputation of Transcriptomics Profiles

Qing Wang, Wen-jie Chen, Bo Li +3

Histopathology, particularly hematoxylin and eosin (H\&E) staining, plays a critical role in diagnosing and characterizing pathological conditions by highlighting tissue morphology…